Filing Details
- Accession Number:
- 0001140361-15-035128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-15 17:15:38
- Reporting Period:
- 2015-09-11
- Filing Date:
- 2015-09-15
- Accepted Time:
- 2015-09-15 17:15:38
- SEC Url:
- Form 4 Filing
Issuer
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1427048 | Josh Drake | C/O Vca Inc. 12401 West Olympic Boulevard Los Angeles CA 90064 | President, Antech Diagnostics | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Disposition | 2015-09-11 | 2,000 | $55.55 | 50,552 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2015-09-15 | 8,584 | $18.94 | 59,136 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2015-09-15 | 12,561 | $56.49 | 46,575 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-09-15 | 8,584 | $0.00 | 8,584 | $18.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,584 | 2017-08-26 | No | 4 | M | Direct |
Footnotes
- The transaction was executed in multiple trades at prices ranging from $55.50 to $55.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected.
- The transaction was executed in multiple trades at prices ranging from $56.40 to $56.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected.
- The option vests in four equal annual installments beginning on August 27, 2013.
Billionaire Hedge Funds
